Erudio Healtherudio.com
Sponsor
University College, London trials: what clinicians said in public
An HCP commentary report on 1 clinical trial sponsored by University College, London: SARON. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 6 more trials with public commentary and no report yet.
Listed by lead sponsor as registered on ClinicalTrials.gov (University College, London). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| SARON NCT02417662 · University College, London | oligometastatic non-small cell lung cancer | Not applicable | 315 | 81 | Deep | Nov 1, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| RAMPART NCT03288532 · University College, London DeepView → | intermediate- or high-risk resected renal cell carcinoma | Phase 3 | Deep | View | |||
| STAMPEDE2 NCT06320067 · University College, London DeepView → | metastatic hormone-sensitive prostate cancer | Phase 3 | Deep | View | |||
| ABC-02 NCT00262769 · University College, London DeepView → | advanced or metastatic biliary tract cancer | Phase 3 | Deep | View | |||
| NEOPRISM-CRC NCT05197322 · University College, London DeepView → | high-risk stage 2 or 3 MMR-deficient colorectal cancer | Phase 2 | Deep | View | |||
| RADICALS NCT00541047 · University College, London FocusedView → | prostate cancer after radical prostatectomy | Phase 3 | Focused | View | |||
| HER-SAFE NCT05880160 · University College, London FocusedView → | recovered HER2-targeted therapy-related cardiac dysfunction | Not applicable | Focused | View | |||